OBJECTIVE: This investigation tested the hypothesis that selective nNOS inhibition would lower the dynamic microvascular O2 delivery/utilization () balance (which sets the Po(2) mv) in rat skeletal muscle at rest and during contractions. METHODS: Anesthetized male Sprague-Dawley rats had their spinotrapezius muscles exposed for blood flow (radiolabeled microspheres), (direct Fick calculation), Po(2) mv (phosphorescence quenching), or exteriorized for force production measurement during electrically induced contractions (1 Hz, 6-8 V, 180 seconds) pre- and post-nNOS inhibition with 2.1μmol/kg of the selective nNOS inhibitor SMTC. RESULTS: At rest, spinotrapezius blood flow was not different whereas SMTC reduced (↓27%) resulting in an elevated precontracting baseline Po(2) mv (control: 31.2±1.6, SMTC: 37.1±2.0mmHg, p<0.05). Following contractions onset SMTC speeded the time to reach 63% of the overall Po(2) mv kinetics response (control: 22.5 ± 1.6, SMTC: 16.9±1.4seconds, p<0.05). During the contracting steady-state, SMTC reduced spinotrapezius blood flow (↓17%) and (↓17%) such that Po(2) mv was not different (control: 22.8±1.6, SMTC: 22.7±2.1mmHg, p>0.05) which occurred despite an elevated (↑∼8%) muscle force production. CONCLUSIONS: These data demonstrate important physiological roles for nNOS-derived NO during contractions in healthy rat skeletal muscle and implicate maladaptations in nNOS function in pathological conditions associated with reduced NO bioavailability.
OBJECTIVE: This investigation tested the hypothesis that selective nNOS inhibition would lower the dynamic microvascular O2 delivery/utilization () balance (which sets the Po(2) mv) in rat skeletal muscle at rest and during contractions. METHODS: Anesthetized male Sprague-Dawley rats had their spinotrapezius muscles exposed for blood flow (radiolabeled microspheres), (direct Fick calculation), Po(2) mv (phosphorescence quenching), or exteriorized for force production measurement during electrically induced contractions (1 Hz, 6-8 V, 180 seconds) pre- and post-nNOS inhibition with 2.1μmol/kg of the selective nNOS inhibitor SMTC. RESULTS: At rest, spinotrapezius blood flow was not different whereas SMTC reduced (↓27%) resulting in an elevated precontracting baseline Po(2) mv (control: 31.2±1.6, SMTC: 37.1±2.0mmHg, p<0.05). Following contractions onset SMTC speeded the time to reach 63% of the overall Po(2) mv kinetics response (control: 22.5 ± 1.6, SMTC: 16.9±1.4seconds, p<0.05). During the contracting steady-state, SMTC reduced spinotrapezius blood flow (↓17%) and (↓17%) such that Po(2) mv was not different (control: 22.8±1.6, SMTC: 22.7±2.1mmHg, p>0.05) which occurred despite an elevated (↑∼8%) muscle force production. CONCLUSIONS: These data demonstrate important physiological roles for nNOS-derived NO during contractions in healthy rat skeletal muscle and implicate maladaptations in nNOS function in pathological conditions associated with reduced NO bioavailability.
Authors: Ilkka Heinonen; Shunsaku Koga; Kari K Kalliokoski; Timothy I Musch; David C Poole Journal: Exerc Sport Sci Rev Date: 2015-07 Impact factor: 6.230
Authors: Daniel M Hirai; Steven W Copp; Scott K Ferguson; Clark T Holdsworth; K Sue Hageman; David C Poole; Timothy I Musch Journal: Nitric Oxide Date: 2017-12-27 Impact factor: 4.427
Authors: Steven W Copp; Daniel M Hirai; Scott K Ferguson; Clark T Holdsworth; Timothy I Musch; David C Poole Journal: J Physiol Date: 2012-06-11 Impact factor: 5.182
Authors: Steven W Copp; Daniel M Hirai; Gabrielle E Sims; Richard J Fels; Timothy I Musch; David C Poole; Michael J Kenney Journal: Respir Physiol Neurobiol Date: 2013-02-27 Impact factor: 1.931
Authors: Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Scott K Ferguson; Timothy I Musch; David C Poole Journal: Am J Physiol Heart Circ Physiol Date: 2012-08-24 Impact factor: 4.733
Authors: Steven W Copp; Clark T Holdsworth; Scott K Ferguson; Daniel M Hirai; David C Poole; Timothy I Musch Journal: J Physiol Date: 2013-03-18 Impact factor: 5.182